Frazier Life Sciences Raises $1.3B for Latest Fund

Frazier Life Sciences has raised $1.3B for its 12th fund, its largest to date, to support early-stage biopharmaceutical startups. The firm, which focuses on biotech and therapeutics investments, previously raised $987M for its 11th fund and also manages a separate fund for small- and mid-cap public biotech companies. Since 2016, Frazier has raised more than $3.6B across five venture funds and $1.7B in public funds since 2021.